MBP 3.23% 3.0¢ metabolic pharmaceuticals limited

ibro 2007 presentation, page-2

  1. 180 Posts.
    lightbulb Created with Sketch. 7
    It would be odd to do this presentation if the results of the next phase of the trial were negative......so, we should look forward to positive results..........just my assumption
 
watchlist Created with Sketch. Add MBP (ASX) to my watchlist

Currently unlisted public company.

arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.